Bayesian individualization via sampling-based methods

Journal of Pharmacokinetics and Biopharmaceutics

Volumn 24, Issue 1, 1996, Pages 103-131

  Wakefield, Jon ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Bayesian individualization; expected loss; population pharmacokinetics; predictive distribution

Indexed keywords

ARTICLE; BAYES THEOREM; DOSE CALCULATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SOLUTION; INDIVIDUALIZATION; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SAMPLING; SIMULATION; SPATIAL SUMMATION;

ALGORITHMS; BAYES THEOREM; PHARMACOKINETICS;

EID: 0029949041     PISSN: 0090466X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02353512     Document Type: Article

References (18)

1. L. B. Sheiner, B. Rosenberg, and K. L. Melmon. Modeling of individual pharmacokinetics for computer-aided drug dosage. Comput. Biomed. Res. 5:441-459 (1972).
2. S. Vozeh and J. J. Steimer. Feedback control methods for drug dosage optimization: concepts, classifications and clinical application. Clin. Pharmacokin. 10:468-480 (1985).
3. J. Gaillot, J. J. Steimer, A. Mallet, J. J. Thebault, and A. Beider. A priori lithium dosage regimen using population characteristics of pharmacokinetic parameters. J. Pharmacokin. Biopharm. 7:579-628 (1979).
4. A. W. Kelman, B. Whiting, and S. M. Bryson. OPT: a package of computer programs for parameter optimization in clinical pharmacokinetics. Br. J. Clin. Pharmacol. 14:247-256 (1982).
5. L. B. Sheiner and S. L. Beal. Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. J. Pharm. Sci. 71:1344-1348 (1982).
6. O. Richter and D. Reinhardt. Methods for evaluating optimal dosage regimens and their application to theophylline. Int. J. Clin. Pharm. 20:564-575 (1982).
7. D. Katz and D. Z. D'Argenio. Implementation and evaluation of control strategies for individualizing dosage regimens, with application to the aminoglycoside antibiotics. J. Pharmacokin. Biopharm. 14:523-537 (1986).
8. D. Z. D'Argenio and D. Katz. Application of stochastic control methods to the problem of individualizing intravenous theophylline therapy. Biomed. Meas. Inform. Contr. 3:115-122 (1988).
9. C. Hu, W. S. Lovejoy, and S. L. Shafer. An efficient control strategy for dosage regimens. J. Pharmacokin. Biopharm. 22:73-94 (1994).
10. J. C. Wakefield. An expected loss approach to the design of dosage regimens via sampling-based methods. Statistician 43:13-29 (1994).
11. A. F. M. Smith and A. E. Gelfand. Bayesian statistics without tears: a sampling resampling perspective. Am. Statist. 46:84-88 (1992).
12. B. D. Ripley. Stochastic Simulation, Wiley, New York, 1987.
13. A. Mallet. A maximum likelihood estimation method for random coefficient regression models. Biometrika 73:645-656 (1986).
14. M. Davidian and A. R. Gallant. Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine. J. Pharmacokin. Biopharm. 20:529-556 (1992).
15. J. C. Wakefield, A. F. M. Smith, A. Racine-Poon, and A. F. Gelfand. Bayesian analysis of linear and nonlinear population models using the Gibbs sampler. Appl. Statist. 43:201-221 (1994).
16. J. E. Bennett and J. C. Wakefield. Comparison of population software using the monoexponential model. J. Pharmacokin. Biopharm. (submitted).
17. N. G. Best, K. K. C. Tan, W. R. Gilks, and D. J. Spiegelhalter. Estimation of population pharmacokinetics using the Gibbs sampler. J. Pharmacokin. Biopharm. (in press).
18. J. C. Wakefield. The Bayesian analysis of population pharmacokinetic models. J. Am. Statist. Assoc. 91:306-319 (1996).